TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase

Tuberous sclerosis complex (TSC) 1 and TSC2 are thought to be involved in protein translational regulation and cell growth, and loss of their function is a cause of TSC and lymphangioleiomyomatosis (LAM). However, TSC1 also activates Rho and regulates cell adhesion. We found that TSC2 modulates acti...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of cell biology Vol. 167; no. 6; pp. 1171 - 1182
Main Authors Goncharova, Elena, Goncharov, Dmitry, Noonan, Daniel, Krymskaya, Vera P
Format Journal Article
LanguageEnglish
Published United States Rockefeller University Press 20.12.2004
The Rockefeller University Press
Subjects
Online AccessGet full text
ISSN0021-9525
1540-8140
DOI10.1083/jcb.200405130

Cover

More Information
Summary:Tuberous sclerosis complex (TSC) 1 and TSC2 are thought to be involved in protein translational regulation and cell growth, and loss of their function is a cause of TSC and lymphangioleiomyomatosis (LAM). However, TSC1 also activates Rho and regulates cell adhesion. We found that TSC2 modulates actin dynamics and cell adhesion and the TSC1-binding domain (TSC2-HBD) is essential for this function of TSC2. Expression of TSC2 or TSC2-HBD in TSC2-/- cells promoted Rac1 activation, inhibition of Rho, stress fiber disassembly, and focal adhesion remodeling. The down-regulation of TSC1 with TSC1 siRNA in TSC2-/- cells activated Rac1 and induced loss of stress fibers. Our data indicate that TSC1 inhibits Rac1 and TSC2 blocks this activity of TSC1. Because TSC1 and TSC2 regulate Rho and Rac1, whose activities are interconnected in a reciprocal fashion, loss of either TSC1 or TSC2 function may result in the deregulation of cell motility and adhesion, which are associated with the pathobiology of TSC and LAM.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
Abbreviations used in this paper: ERM, ezrin-radixin-moesin; GAP, GTPase-activating protein; LAM, lymphangioleiomyomatosis; LAMD, human LAM-derived; mTOR, mammalian target of rapamycin; PDGFR, PDGF receptor; S6K, p70 S6 kinase; SE, standard error; TSC, tuberous sclerosis complex; TSC2-HBD, TSC1-binding domain of TSC2.
Correspondence to Vera P. Krymskaya: krymskay@mail.med.upenn.edu
ISSN:0021-9525
1540-8140
DOI:10.1083/jcb.200405130